Titan Pharmaceuticals (TTNP) SEC Filings & 10K Form $4.03 +0.03 (+0.75%) (As of 11/4/2024 ET) Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends Recent Titan Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView10/24/20248:16 AMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/21/20247:32 AMSire Group Ltd. (Filed by)Titan Pharmaceuticals (Subject)Form SC 13D/A08/15/20248:29 AMTitan Pharmaceuticals (Filer)Form NT 10-Q08/15/20248:29 AMTitan Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/26/20248:39 AMTitan Pharmaceuticals (Filer)Form RW04/05/20243:34 PMSire Group Ltd. (Filed by)Titan Pharmaceuticals (Subject)Form SC 13D/A04/05/20249:13 AMFlores Francisco (Reporting)Titan Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 04/05/20249:14 AMMokhtar Firdauz (Reporting)Titan Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 03/27/20248:45 AMChoong Choon Hau (Reporting)Titan Pharmaceuticals (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/21/202411:19 AMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/18/20243:59 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/08/20244:13 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/28/20233:30 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/28/20233:30 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/15/20233:05 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/14/20233:15 PMTitan Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies BioCardia 10Q Form Longeveron 10Q Form NRx Pharmaceuticals 10Q Form Avalo Therapeutics 10Q Form Biora Therapeutics 10Q Form Alzamend Neuro 10Q Form ANEW Medical 10Q Form Calidi Biotherapeutics 10Q Form CERo Therapeutics 10Q Form IN8bio 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:TTNP) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TTNP Stock Alerts